Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/2783
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorIANNI, Barbara M.-
dc.contributor.authorRAMIRES, Felix J. A.-
dc.contributor.authorSALEMI, Vera M. C.-
dc.contributor.authorFERNANDES, Fabio-
dc.contributor.authorOLIVEIRA, Adriana M.-
dc.contributor.authorPESSOA, Fernanda G.-
dc.contributor.authorFONSECA, Keila C. B.-
dc.contributor.authorARTEAGA, Edmundo-
dc.contributor.authorNASTARI, Luciano-
dc.contributor.authorMADY, Charles-
dc.date.accessioned2013-10-11T21:17:41Z-
dc.date.available2013-10-11T21:17:41Z-
dc.date.issued2012-
dc.identifier.citationJOURNAL OF CARDIAC FAILURE, v.18, n.8, suppl.1, p.S24-S24, 2012-
dc.identifier.issn1071-9164-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/2783-
dc.description.abstractPurpose: Chagas cardiomyopathy(CM) is characterized by a large amount of fibrosis and inflamation. As simvastatin (simva) has anti-inflamatory effects, we hypothetized that it could be an important drug in the treatment of patients with CM. The purpose was to evaluate simva in the myocardium remodeling and inflammation in na animal model of CM. Methods: 123 hamsters were divided: C-controls(25), CSimva-controls with simva 10mg/Kg/day(25), Simva1-infected treated from beginning with the same dose of simva(25), Simva2-infected treated after 4 months(24); Infect-untreated(24). Follow-up of 10 months. Interstitial collagen volume fraction (ICVF) RV and LV measured using videomorphometry and picrosirius red stained heart. Metalloproteinase9 (MMP9) was obtained by zymography. Gene expression of TNFalpha, IFNgamma, IL10 by real time PCR and ΔCt. Survival by Kaplan-Meier and log rank. Comparison between groups by Kruskal-Wallis; p≤0.05. Results: Infected animals Simva1=189±133 days Simva2=150±124; Infect=138±123) lived less than controls (C=257±80; CSimva=283±58)(p≤0.05) with no difference among infected. ICVF-RV(%) was greater in infected groups (Simva1=3.88±1.14, Simva2=2.22±0.64; Infect=4.38±0.83) than in controls C=1.12±0.31; CSimva=2.18±0.73)(p≤0.05)with no difference among infected groups. ICVF-LV(%) was greater in infected animals (Simva1=1.83±1.01, Simva2=1.52±0.93; Infect=3.01±0.66) than in controls (C=0.68±0.31; CSimva=0.81±0.28)(p≤0.05) with no difference among infected. MMP9 was higher in infected groups (Simva1=2394±2441, Simva2=5673±4091; Infect=2392±2042) compared to controls (C=954±2332; CSimva=454±1123)(p≤0.05) with no difference among infected. TNFalpha did not have difference among infected groups (Simva1=5.33±3.66, Simva2=4.44±2.17; Infect=6.13±3.24). IFNgamma in infected groups (Simva1=5.47±3.56, Simva2=4.46±2.08; Infect=4.21±2.09) was higher than in controls (C=8.50±2.59; CSimva=6.84±2.53)(p≤0.05) with no difference among infected. IL10 in infected animals (Simva1=9.07±4.62, Simva2=7.76±4.77; Infect=8.11±4.48) did not have difference and the values were greater than controls (C=14.11±4.40; CSimva=12.55±3.90)(p≤0.05). Conclusions: Simva did not attenuate deposition of interstitial collagen, did not change dynamics of collagen degradation, did not decrease inflammation, and did not reduce mortality.-
dc.language.isoeng-
dc.publisherCHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS-
dc.relation.ispartofJournal of Cardiac Failure-
dc.rightsrestrictedAccess-
dc.titleLack of Effect of Simvastatin on Structural Remodeling in Animal Model of Chagas Cardiomyopathy-
dc.typeconferenceObject-
dc.rights.holderCopyright CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS-
dc.description.conferencedateSEP 09-12, 2012-
dc.description.conferencelocalSeattle - WA, EUA-
dc.description.conferencename16th Annual Scientific Meeting of the Heart-Failure-Society-of-America-
dc.subject.wosCardiac & Cardiovascular Systems-
dc.type.categorymeeting abstract-
dc.type.versionpublishedVersion-
hcfmusp.description.beginpageS24-
hcfmusp.description.endpageS24-
hcfmusp.description.issue8-
hcfmusp.description.issuesuppl 1-
hcfmusp.description.volume18-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000307679700075-
hcfmusp.publisher.cityPHILADELPHIA-
hcfmusp.publisher.countryUSA-
dc.description.indexMEDLINE-
Appears in Collections:

Comunicações em Eventos - FM/MCP
Departamento de Cardio-Pneumologia - FM/MCP

Comunicações em Eventos - HC/InCor
Instituto do Coração - HC/InCor

Comunicações em Eventos - LIM/11
LIM/11 - Laboratório de Cirurgia Cardiovascular e Fisiopatologia da Circulação


Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.